The gene therapy market was valued at US$3.425 billion in 2018 and is anticipated to grow at a CAGR of 16.92% to reach a market size of US$8.748 billion by 2024. gene therapy drugs are being commercialized significant income is as yet being acquired by clinical research, this is on the grounds that it includes the utilization of quality treatment on people, hence, efforts are made to focus on clinical examination prior to being market-ready. Subsequently, developing clinical trials globally is further driving the market development in the estimated time frame and in the coming years. The gene therapy market has been segmented on the basis of type, technique, vector type, indication, and geography.